| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 780 | ₹0.8 -20% | 17,0504.76% |
| - | - | 800 | ₹1.1 -4.34% | 43,4000% |
| - | - | 820 | ₹2.5 0% | 7750% |
| 1,5500% | ₹89.05 0% | 830 | ₹2.5 0% | 7750% |
| - | - | 840 | ₹1.9 -19.14% | 13,95063.63% |
| 5,4250% | ₹69 0% | 850 | ₹2.15 -27.11% | 86,0256.73% |
| 00% | ₹60 0% | 860 | ₹2.8 -30% | 10,8507.69% |
| - | - | 870 | ₹3.45 -34.28% | 13,9500% |
| 7750% | ₹48 0% | 880 | ₹5.05 -24.62% | 95,325-0.80% |
| - | - | 890 | ₹6.65 -23.56% | 33,32534.37% |
| 2,25,525-4.27% | ₹42.4 24.52% | 900 | ₹8.6 -26.49% | 2,61,175-21.62% |
| 86,800-5.88% | ₹34.65 21.57% | 910 | ₹11.55 -22.48% | 1,13,150-4.57% |
| 1,48,025-8.17% | ₹29.7 33.48% | 920 | ₹15.15 -20.26% | 1,77,47519.27% |
| 1,17,02537.27% | ₹24.5 43.69% | 930 | ₹19 -21.32% | 63,550203.70% |
| 1,26,325111.68% | ₹19.65 45.55% | 940 | ₹23.95 -15.96% | 37,975250% |
| 3,10,77523.00% | ₹15.05 48.27% | 950 | ₹30.45 -18.14% | 92,225-33.88% |
| 1,14,70039.62% | ₹11.65 47.46% | 960 | ₹38.35 -14.96% | 11,6250% |
| 37,2004700% | ₹9.2 -76.34% | 970 | ₹58.05 0% | 7750% |
| 99,97557.31% | ₹6.4 50.58% | 980 | ₹53.85 -23.07% | 4,650500% |
| 13,95050% | ₹5.9 73.52% | 990 | - | - |
| 2,21,65032.40% | ₹4 63.26% | 1,000 | ₹64.75 -11.72% | 22,4750% |
| 32,550110% | ₹2.25 36.36% | 1,020 | - | - |
| 11,62536.36% | ₹1.25 31.57% | 1,040 | - | - |
| - | - | 1,050 | ₹136.25 0% | 7,7500% |
| 1,5500% | ₹4.9 0% | 1,080 | - | - |
| 4,6500% | ₹0.3 0% | 1,100 | ₹177 0% | 4,6500% |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
